āĻšā§āĻŽILMN âĸ NASDAQ
add
āĻāϞā§āĻŽāĻŋāύāĻž
ā§ā§.ā§Žā§Ž$
āĻāĻŖā§āĻāĻž āĻĒāϰā§:(ā§Ļ.ā§Ļ⧍ā§Ŧ%)+ā§Ļ.ā§Ļ⧍ā§Ļ
ā§ā§.⧝ā§Ļ$
āĻŦāύā§āϧ āĻāĻā§: ⧍ āĻŽā§, ā§Ŧ:ā§Šā§¯:ā§Ļā§§ PM GMT -ā§Ē · USD · NASDAQ · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āϏā§āĻāĻāĻŽāĻžāϰā§āĻāĻŋāύ āϝā§āĻā§āϤāϰāĻžāώā§āĻā§āϰ-āĻ āϤāĻžāϞāĻŋāĻāĻžāĻā§āĻā§āϤ āϏāĻŋāĻāĻŋāĻāϰāĻŋāĻāĻŋāĻŽāĻžāϰā§āĻāĻŋāύ āϝā§āĻā§āϤāϰāĻžāώā§āĻā§āϰ-āĻ āĻšā§āĻĄāĻā§ā§āĻžāϰā§āĻāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§ā§Ŧ.ā§Ģā§§$
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§ā§.ā§Ļ⧍$ - ā§ā§¯.⧍⧍$
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§Ŧā§Ž.ā§ā§Ļ$ - ā§§ā§Ģā§Ŧ.ā§Ŧā§Ŧ$
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
⧧⧍.ā§Šā§ŠāĻļāĻ¤Â āĻā§ USD
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
⧍⧍.ā§Ēā§¯Â āϞāĻž
P/E āĻ
āύā§āĻĒāĻžāϤ
-
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
-
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
NASDAQ
āĻāĻŦāϰ⧠āϰā§ā§āĻā§
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(USD) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ēinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§§ā§§ā§Ļ.ā§Ēā§Ļ āĻā§ | -ā§§.ā§Ŧā§Ļ% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§Žā§Ģ.ā§§ā§Ļ āĻā§ | ā§§.ā§Ēā§Š% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§§ā§Ž.ā§ā§Ļ āĻā§ | ⧍ā§Ļā§Ŧ.ā§Žā§Ŧ% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | â | â |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | ā§Ļ.ā§Žā§Ŧ | ā§Ģā§§ā§Ē.⧍⧝% |
EBITDA | -ā§Š.ā§Ģā§Ļ āĻā§ | -ā§Ēā§Žā§Š.ā§Šā§Š% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ā§Ļ.ā§Ļā§Ļ% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(USD) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ēinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ⧧⧍⧍.ā§Ļā§Ļ āĻā§ | ā§§ā§Ģ.ā§ā§Ģ% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§Ŧā§Šā§Ļ.ā§Šā§Ļ āĻā§ | -ā§Šā§.ā§Ŧā§Ŧ% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§Šā§¯ā§Š.ā§Ļā§Ļ āĻā§ | -⧝.⧝⧝% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§¨ā§Šā§.ā§Šā§Ļ āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§§ā§Ģ.ā§Žā§Ē āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§Ģ.ā§§ā§Š | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | -ā§Ē.ā§Šā§Ļ% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | â | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(USD) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ēinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§§ā§Ž.ā§ā§Ļ āĻā§ | ⧍ā§Ļā§Ŧ.ā§Žā§Ŧ% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | ā§Šā§Ŧ.ā§Ēā§Ļ āĻā§ | ā§Ŧ⧍.ā§Ģā§Ļ% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§Ē.ā§Žā§Ļ āĻā§ | ā§Ēā§Š.ā§Ģā§Š% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§Ē.ā§ā§Ļ āĻā§ | -ā§ā§Ē.ā§Ļā§% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | ⧍ā§Ģ.ā§Žā§Ļ āĻā§ | ā§§ā§§ā§Š.⧍⧍% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| ā§§.ā§Ģā§§Â āĻā§ | -⧝⧧.ā§Šā§Ļ% |
āϏāĻŽā§āĻĒāϰā§āĻā§
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
ā§§ā§¯ā§¯ā§Ž
āϏāĻĻāϰ āĻĻāĻĒā§āϤāϰ
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
⧝,ā§Ļā§Ļā§Ļ